CLINICAL_TRIALS
research
· 2024-06-07
Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade Inflammation [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial evaluating umbilical cord-derived mesenchymal stem cells for aging-related low-grade inflammation; currently not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nguyen Ton Ngoc Huynh | Conditions: Inflammatory Disease, Aging Problems | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING